Skip to Main Content

Author Details

Ken J Kron
Princess Margaret Cancer Centre, University Health Network
2009
27
21
PMIDPaper TitleJournal TitlePublished Year
33242413The Transition from Quiescent to Activated States in Human Hematopoietic Stem Cells Is Governed by Dynamic 3D Genome Reorganization.Cell Stem Cell2021
34642184Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors.Cancer Res2021
31974375Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.Nat Commun2020
30889379The Proteogenomic Landscape of Curable Prostate Cancer.Cancer Cell2019
31735626Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.Cancer Cell2019
29924804Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo.PLoS Biol2018
28068672Genomic hallmarks of localized, non-indolent prostate cancer.Nature2017
28167242Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.Transl Oncol2017
28783165TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer.Nat Genet2017
28693181Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.Oncol Lett2017
26908456Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation.Oncotarget2016
27424808Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.Cancer Cell2016
27571262Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer.Nat Genet2016
26981160Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis.Clin Epigenetics2016
24311408Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression.Prostate2014
25473436Enhancer alterations in cancer: a source for a cell identity crisis.Genome Med2014
25277202Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.Oncotarget2014
24667637Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation.J Clin Invest2014
24703897Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.Eur J Cancer2014
24651255Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids.Sci Rep2014
23549870Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancer.Clin Cancer Res2013
22452941Correlation of ERG expression and DNA methylation biomarkers with adverse clinicopathologic features of prostate cancer.Clin Cancer Res2012
22874102Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.Epigenetics2012
21207416Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.Int J Cancer2011
20212450DNA methylation of HOXD3 as a marker of prostate cancer progression.Lab Invest2010
27463194How to Deal with Batch Effect in Sequential Microarray Experiments?Mol Inform2010
19283074Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.PLoS One2009
  • 1 - 27 of 27

Recommended Authors

Edward O'Connor
Dana-Farber Cancer Institute
Career Start Year 2017
Number of shared co-authors 35
Jing Li
Center for Translational Medicine, Second Military Medical University
Career Start Year 2014
Number of shared co-authors 11
Ren?? B??ttcher
Universitat Pompeu Fabra
Career Start Year 2012
Number of shared co-authors 10
Paul Lloyd
Bluestar Genomics Inc.
Career Start Year 2010
Number of shared co-authors 5
Hui Shen
Van Andel Institute
Career Start Year 2010
Number of shared co-authors 0
Suhn K Rhie
Keck School of Medicine of USC
Career Start Year 2009
Number of shared co-authors 2
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 15
Alfonso Urbanucci
Northwestern University Feinberg School of Medicine Chicago
Career Start Year 2008
Number of shared co-authors 6
Ram S Mani
UT Southwestern Medical Center
Career Start Year 2008
Number of shared co-authors 32
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 14
Leander Van Neste
Maastricht University Medical Center
Career Start Year 2007
Number of shared co-authors 1
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 1
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 40
Yassen Assenov
German Cancer Research Center (DKFZ)
Career Start Year 2006
Number of shared co-authors 4
Christina M??ller-Koop
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2006
Number of shared co-authors 4
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 8
Gong-Hong Wei
Fudan University Shanghai Cancer
Career Start Year 2004
Number of shared co-authors 12
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 3
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Benjamin P Berman
Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem
Career Start Year 2000
Number of shared co-authors 0
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 2
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 4
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 2
Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
Career Start Year 1997
Number of shared co-authors 2
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 13
Matthew L Freedman
Dana-Farber Cancer Institute
Career Start Year 1993
Number of shared co-authors 41
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 15
Christoph Plass
German Cancer Research Center
Career Start Year 1982
Number of shared co-authors 13

Collaborators

Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 19
Bharati Bapat
Mt Sinai Hospital
Co-authored papers 13
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers 13
Neil E Fleshner
University of Toronto
Co-authored papers 12
John Trachtenberg
University of Toronto, University Health Network
Co-authored papers 6
Laurent Briollais
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Co-authored papers 6
Paul C Boutros
University of California los angeles
Co-authored papers 6
Robert G Bristow
University of Toronto
Co-authored papers 6
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers 5
Ekaterina Olkhov-Mitsel
University of Toronto
Co-authored papers 5
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers 5
Alex Murison
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Stanley Zhou
Princess Margaret Cancer Research Centre
Co-authored papers 5
Takafumi N Yamaguchi
University of California los angeles
Co-authored papers 4
Hilmi Ozcelik
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 4
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 3
Musaddeque Ahmed
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 3
Swneke D Bailey
Research Institute of the McGill University Health Centre
Co-authored papers 3
Julie Livingstone
University of California los angeles
Co-authored papers 3
Daniel D De Carvalho
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Giacomo Grillo
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Parisa Mazrooei
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 3
Shadrielle Melijah G Espiritu
Ontario Institute for Cancer Research
Co-authored papers 2
Colin C Collins
University of British Columbia
Co-authored papers 2
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers 2
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 2
Natalie S Fox
University of California los angeles
Co-authored papers 2
Release 1.2